Mike Pelfrey Injury Update: Mets Await Second Opinion On Elbow

The bad news might be getting worse for Mets pitcher Mike Pelfrey.

NJ.com is reporting that an MRI revealed a partially-torn ulnar collateral ligament, per a source, and that the results were sent to notable surgeon Dr. James Andrews in Alabama. The Mets have only said Pelfrey is dealing with joint swelling and Pelrey told reporters Tuesday that his arm felt great. He was placed on the 15-day DL for the first time in his career on Tuesday.

If Pelfrey does have a badly-torn UCL, it could require Tommy John surgery, but the hope is that the swelling will go down and he can avoid surgery. Tommy John surgery would sideline Pelfrey for more than a year.

Pelrey has been a bright spot early in the season for the Mets. He has given up five earned runs on 24 hits over 19 2/3 innings. The Mets were 2-1 in his starts, although he didn't record a decision.

For more on the Mets, be sure to check out our blog Amazin' Avenue and SB Nation New York for all the latest news and updates.

Trending Discussions

X
Log In Sign Up

forgot?
Log In Sign Up

Forgot password?

We'll email you a reset link.

If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.

Forgot password?

Try another email?

Almost done,

Join SB Nation New York

You must be a member of SB Nation New York to participate.

We have our own Community Guidelines at SB Nation New York. You should read them.

Join SB Nation New York

You must be a member of SB Nation New York to participate.

We have our own Community Guidelines at SB Nation New York. You should read them.

Spinner

Authenticating

Great!

Choose an available username to complete sign up.

In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.